New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England-Reference-Cited by-同舟云学术

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

Published:2016-03-29 Issue:8 Volume:23 Page:631-643
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Harris R. J.¹,Martin N. K.²³,Rand E.⁴,Mandal S.⁵,Mutimer D.⁶⁷,Vickerman P.³,Ramsay M. E.⁵,De Angelis D.¹⁸,Hickman M.³,Harris H.E.⁵

Affiliation:

1. Statistics, Modelling and Economics Department Public Health England London UK

2. Division of Global Public Health University of California San Diego San Diego CA USA

3. School of Social and Community Medicine University of Bristol Bristol UK

4. University of Pennsylvania Philadelphia PA USA

5. Immunisation, Hepatitis and Blood Safety Department National Infection Service Public Health England London UK

6. Liver Unit Queen Elizabeth Hospital Birmingham UK

7. National Institute for Health Research Biomedical Research Unit and Centre for Liver Research University of Birmingham Birmingham UK

8. MRC Biostatistics Unit Cambridge Institute of Public Health Cambridge UK

Funder

National Institute of Allergy and Infectious Diseases

National Cancer Institute, Cairo University

National Institute of Mental Health

National Institute on Drug Abuse

National Institute of Child Health and Human Development

National Heart, Lung, and Blood Institute

National Institute on Aging

National Institute of General Medical Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

Public Health England

National Institutes of Health

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.12529

Reference46 articles.

1. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

2. Public Health England.Hepatitis C in the UK 2015 report.2015. Available at:https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/448710/NEW_FINAL_HCV_2015_IN_THE_UK_REPORT_28072015_v2.pdf

3. Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios

4. Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis

5. Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK;International Journal of Drug Policy;2024-06

2. Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study;International Journal for Equity in Health;2023-06-06

3. Exploratory assessment: Nurse‐led community health worker delivered HCV intervention for people experiencing homelessness;Public Health Nursing;2023-05-02

4. The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018;Journal of Viral Hepatitis;2021-07-29

5. Epidemiology of Hepatitis C Virus: People Who Inject Drugs and Other Key Populations;Hepatitis C: Epidemiology, Prevention and Elimination;2021